Falsification end points for observational studies

JAMA

Volumn 309, Issue 17, 2013, Pages 1769-1770

  Groenwold, Rolf H H ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; INFLUENZA VACCINE;

BODY MASS; ELECTIVE SURGERY; FOREIGN BODY; HEART DEATH; HEART INFARCTION; HUMAN; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS; LETTER; MEDICAL RESEARCH; MORTALITY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RISK FACTOR; SEASONAL VARIATION; SYSTEMATIC ERROR; TREATMENT OUTCOME; VALIDATION PROCESS; VIRUS TRANSMISSION; BIOASSAY; DRUG TOXICITY; EPIDEMIOLOGY; FRAUD; NOTE; OBSERVATION;

CAUSALITY; DRUG TOXICITY; ENDPOINT DETERMINATION; FRAUD; OBSERVATION;

EID: 84877132331     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2013.3089     Document Type: Letter

References (4)

1. Prasad V, Jena AB. Prespecified falsification end points: can they validate true observational associations? JAMA. 2013;309(3):241-242.
2. Lipsitch M, Tchetgen Tchetgen E, Cohen T. Negative controls: a tool for detecting confounding and bias in observational studies. Epidemiology. 2010;21(3):383-388.
3. Redelmeier D, Scales D, Kopp A. Beta blockers for elective surgery in elderly patients: population based, retrospective cohort study. BMJ. 2005;331(7522):932.
4. Groenwold RH, Hoes AW, Hak E. Impact of influenza vaccination on mortality risk among the elderly. Eur Respir J. 2009;34(1):56-62.